Our mission is to make exceptional, innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases.

Taking Big Steps

Visit our Online Magazine

MorphoSys' mission

MorphoSys mission is to make exceptional, innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases. Our focus is on cancer. Innovative technologies and smart development strategies are central to our approach.

02/03/2021
MorphoSys's Licensing Partner GSK Shared Preliminary Results From...
01/03/2021
Ad hoc: MorphoSys AG preliminary results for the fiscal year 2020...
25/01/2021
MorphoSys AG: MorphoSys and I-Mab Announce First Patient Dosed in U.S....
12/01/2021
MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug...
11/01/2021
MorphoSys To Present At the 39th Annual J.P. Morgan Healthcare Conference
06/01/2021
MorphoSys Appoints Sung Lee as Chief Financial Officer
05/01/2021
MorphoSys and Incyte Announce the Acceptance of the Swissmedic Marketing...
17/12/2020
MorphoSys AG: Corporate Calendar 2021
07/12/2020
Data Evaluating Tafasitamab with and without Lenalidomide in Combination...
02/12/2020
MorphoSys' Licensee Announces Approval by the European Commission for...

February 26, 2021
Webcast
SVB Leerink Global Healthcare Conference

Full details